ArticleBlood advances2022
Tam CS, Dimopoulos M, Garcia-Sanz R, et al. Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies. Blood Adv. 2022;6(4):1296-1308.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.